Cirrhosis Regression in HCV Patients After Antiviral TherapyCirrhosis Regression in HCV Patients After Antiviral Therapy
Do the majority of patients with cirrhosis who achieve a sustained virological response develop cirrhosis regression? This new study investigates. Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 2, 2015 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Identification of Protein Receptors for Coronaviruses by Mass Spectrometry
As obligate intracellular parasites, viruses need to cross the plasma membrane and deliver their genome inside the cell. This step is initiated by the recognition of receptors present on the host cell surface. Receptors can be major determinants of tropism, host range, and pathogenesis. Identifying virus receptors can give clues to these aspects and can lead to the design of intervention strategies. Interfering with receptor recognition is an attractive antiviral therapy, since it occurs before the viral genome has reached the relative safe haven within the cell. This chapter describes the use of an immunoprecipitation app...
Source: Springer protocols feed by Microbiology - February 28, 2015 Category: Microbiology Source Type: news
Protecting Children: Influenza Updates for Clinicians
February 26, 2015, 2:00-3:00 PM EST. During this webinar, clinicians will learn about the current state of flu activity related to children, the importance of continued vaccination despite the mismatch and low vaccine effectiveness, and strategies for using antiviral therapy early to prevent and treat influenza. (Source: PHPartners.org)
Source: PHPartners.org - February 18, 2015 Category: Global & Universal Source Type: news
Triple Antiviral Therapy Promising for Mild - to - Moderate COVID - 19
Duration of viral shedding shorter with combination of lopinavir - ritonavir, ribavarin, interferon beta - 1b (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 11, 2014 Category: Respiratory Medicine Tags: Infections, Nursing, Pharmacy, Pulmonology, Critical Care, Emergency Medicine, Journal, Source Type: news
5-Year-Old Boy In NYC Tests Negative For Ebola
(Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - October 27, 2014 Category: Consumer Health News Source Type: news
Varicella-Zoster Virus Infection in Children and AdolescentsVaricella-Zoster Virus Infection in Children and Adolescents
Which children should receive antiviral therapy for chickenpox? U.S. Pharmacist (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2014 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news
J&J's Hera Therapeutics Presents Antiviral Drug For HPV
Scientists from Hera Therapeutics, part of the Janssen Labs under the Johnson & Johnson’s external R&D engine, presented results suggesting that its small molecule HTI-1968 has potential as a direct-acting antiviral therapy against Human Papilloma Virus (HPV). (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - August 27, 2014 Category: Pharmaceuticals Source Type: news
Relapse Rates in Chronic HBV After Stopping AntiviralsRelapse Rates in Chronic HBV After Stopping Antivirals
How can clinicians prevent relapse in patients with chronic hepatitis B after discontinuation with antiviral therapy? Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 14, 2014 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Influenza: Complications in 1 in 3 Previously Healthy Kids Influenza: Complications in 1 in 3 Previously Healthy Kids
As many as 1 in 3 children seeking treatment for influenza-like illnesses at the peak of influenza season are at high risk of suffering severe complications, arguing for antiviral therapy scripts. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 4, 2014 Category: Consumer Health News Tags: Pediatrics News Source Type: news
Should donor blood be screened for hepatitis E?
Conclusion
This study estimated the prevalence of hepatitis E virus in blood donors and found a higher than expected figure of around one infection in every 2,848 donors.
They found the infection was passed to the recipient of the blood in some cases, but this did not cause significant illness and recipients were able to clear the virus from their bodies naturally in most cases.
This study, which coincides with World Hepatitis Day, increases our awareness that the prevalence of hepatitis E in England might be higher than previously assumed.
A second issue stemming from the study is whether, given the higher than expected...
Source: NHS News Feed - July 28, 2014 Category: Consumer Health News Tags: Medical practice Source Type: news
Drug that reduces abdominal fat in HIV patients also may reduce fat in liver
(Massachusetts General Hospital) The only drug to receive Food and Drug Administration approval for reduction of the abdominal fat deposits that develop in some patients receiving antiviral therapy for HIV infection may also reduce the incidence of fatty liver disease in such patients. Massachusetts General Hospital investigators report that six months of daily injections of tesamorelin significantly reduced fat in the liver without affecting glucose metabolism. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 19, 2014 Category: Global & Universal Source Type: news
Findings suggest antivirals underprescribed for patients at risk for flu complications
(Infectious Diseases Society of America) Patients likely to benefit the most from antiviral therapy for influenza were prescribed these drugs infrequently during the 2012-2013 influenza season, while antibiotics may have been overprescribed. Published in Clinical Infectious Diseases and now available online, the findings suggest more efforts are needed to educate clinicians about the appropriate use of antivirals and antibiotics in the outpatient setting. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 17, 2014 Category: Infectious Diseases Source Type: news
Predicting the outcome of hepatitis C virus treatment
(Journal of Clinical Investigation) A study published in the Journal of Clinical Investigation identifies a marker that can identify patients likely to have an HCV relapse after antiviral therapy. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2014 Category: Infectious Diseases Source Type: news
Antiviral therapy can prevent liver cancer in chronic hepatitis B patients
(American Gastroenterological Association) One of the most severe complications of hepatitis B is the development of liver cancer, which is responsible for approximately 745,000 deaths worldwide each year. Two new studies appearing in the June issue of Gastroenterology provide strong evidence that antiviral therapy can reduce the risk of liver cancer in patients with chronic hepatitis B infection. Gastroenterology is the official journal of the American Gastroenterological Association. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2014 Category: Infectious Diseases Source Type: news
Antiviral therapy may prevent liver cancer in hepatitis B patients
(Henry Ford Health System) Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma. 'The results of this study allow us to reassure our patients that we are not just treating their viral levels, but that antiviral therapy may actually lessen their chance of developing liver cancer,' said the study's lead investigator, Henry Ford Health System's Stuart C. Gordon, M.D. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 9, 2014 Category: Global & Universal Source Type: news
